Replies to post #15383 on Guided Therapeutics Inc (GTHP)

[2themoon1]

everyone has their reason for selling...a 2 year delay getting a USFDA study off the ground might be a good place to start. Using your primiitive valuation metrics, i suppose because some people were selling Citi Group once upon a time at $1 that represented fair value?????
i won't do your homework for you but just go and have a look at other cancer screening device companies and see where they were trading at the inflection points of 1. Starting the study. 2. completing and submitting the study. 3. approval. They are 12% in on the USFDA study and are very much lagging those that you would find in that comp group